Prime Medicine Analyst Ratings
Prime Medicine Analyst Ratings
Buy Rating Affirmed for Prime Medicine, Inc. on FDA Trial Approval and Strong Financials
Prime Medicine Analyst Ratings
Buy Rating Affirmed for Prime Medicine, Inc. on Robust Preclinical Data and Prime Editing Technology Prospects
Prime Medicine Analyst Ratings
Jefferies Issues a Buy Rating on Prime Medicine, Inc. (PRME)
Buy Rating Affirmed for Prime Medicine, Inc. on Strong Preclinical Data and Promising Clinical Outlook
Prime Medicine Analyst Ratings
Buy Rating Affirmed for Prime Medicine, Inc. on Groundbreaking Genetic Editing Platform and Strategic Progress
Prime Medicine Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME), Arvinas Holding Company (ARVN) and Viridian Therapeutics (VRDN)
Prime Medicine Analyst Ratings
Prime Medicine Analyst Ratings
Analysts' Top Healthcare Picks: Prime Medicine, Inc. (PRME), Alcidion Group Limited (AU:ALC)
Buy Rating Justified: Prime Medicine's Promising Clinical Prospects and Innovative Gene Editing Technology Poised for Growth
Prime Medicine Analyst Ratings
Buy Rating Affirmed for Prime Medicine, Inc. on Anticipated IND Filing and Strong Gene Editing Pipeline
Citigroup Initiates Coverage On Prime Medicine With Neutral Rating, Announces Price Target of $10
Prime Medicine Analyst Ratings